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cholesterol (HDL-C)Abstract Background: Diabetes is associated with a high risk of cardiovascular disease (CVD).
The classic ‘‘diabetic dyslipidemia’’ is mostly described as hypertriglyceridemia and low levels of
HDL-C. Elevated LDL-C is an established risk factor for CVD.
Objective: Identify the pattern of dyslipidemia in children and adolescents with type 1 diabetes
mellitus regularly following at Diabetes Endocrine and Metabolism Pediatric Unit (DEMPU) at
Children’s Hospital of Cairo University; and to detect its relation to different risk factors.
Methods: Sixty children and adolescents with T1DM, (34 males and 26 females, mean age
12.5 ± 2.4 years and mean duration of diabetes 4.3 ± 2.7 years) were evaluated by full history
and clinical examination including 3 day dietetic history for analysis, BMI and waist circumference.
Records were revised for mean blood glucose and HbA1c. Fasting lipid proﬁle (total cholesterol,
triglycerides, HDL-C and LDL-C) was performed. Thirty-nine healthy age and sex matched
children were included as control for lipid proﬁle.
Results: Dyslipidemia signiﬁcantly more frequent among T1DM children and adolescents com-
pared to control subjects (39/60, 65% vs. 11/39, 28.2%, p< 0.001); and the dyslipidemic (39/60)
compared to normoalbuminuric (21/60) children had signiﬁcantly higher mean waist circumference.
Both groups were comparable regarding age, age at onset and duration of diabetes, family history
of diabetes and CVD, degree of glycemic control and dietary analysis.
Conclusion: Dyslipidemia is signiﬁcantly more frequent in children and adolescents with T1DM
compared to non-diabetic peers. The most frequent type of dyslipidemia was high LDL-C and
low HDL-C in the dyslipidemic group.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Pediatric
Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Children diagnosed with type 1 diabetes have a high risk of
early subclinical and clinical cardiovascular disease (CVD).1–3
The American Heart Association categorizes children with type
1 diabetes in the highest tier for cardiovascular risk and recom-
mends both lifestyle and pharmacological treatment for those
with elevated LDL cholesterol levels.4,5
Global IDF/ISPAD Guideline for Diabetes in Childhood
and Adolescence, 2014 recommended screening for fasting
blood lipids when diabetes is stabilized in children aged over
10 years. If there is a family history of hypercholesterolaemia,
early CVD or if the family history is unknown, screening
should start at age 2 years. If normal results are obtained,
screening should be repeated every 5 years.6
Objectives
To study the pattern of dyslipidemia in children and
adolescents with type 1 diabetes mellitus; and its relation to
the duration of diabetes, degree of glycemic control, body
habitus, dietary intake and epidemiological risk factors
including family history and life-style.Materials and methods
Study population
The current study included 60 children and adolescents regu-
larly followed at the Diabetes Endocrine and Metabolism
Pediatric Unit (DEMPU), Children’s Hospital, Cairo
University. Subjects were eligible if they were between 9 and
16 years of age and had type 1 diabetes mellitus (T1DM) for
one year or more. Exclusion criteria were the presence of
associated hypothyroidism and the use of thyroxin therapy
or lipid lowering medications. Thirty-nine healthy age and
sex matched children and adolescents were included as control.
Procedures
Detailed history was taken from included patients including
the following:
 Detailed medical history including; chronological age, dura-
tion and age at onset of diabetes, type and dose of insulin,
compliance to diet and insulin therapy, detailed dietetic his-
tory in addition to family history of diabetes, hypertension,
coronary heart disease and stroke, and history suggestive of
diabetic microvascular and macrovascular complications.
 Diet history: each patient was asked for detailed food
intake for 3 consecutive days, 3 meals and snacks with
emphasis on total caloric intake and fat content (three days
recall). A nutritionist had analyzed all components of
child’s diet and calculated the mean values for total caloric
intake (kcal/d), intake of fats, CHO and proteins in grams
per day as well as and caloric intake derived from fats
(kcal/d).
 Physical activity: type and duration (h/day) of weekly activ-
ity was classiﬁed as ‘‘mild’’ if regular daily activity, like walk-
ing, running, playing football, ascending and descendingstairs or bicycling; and ‘‘intense’’ if regular sports are done,
like swimming, basketball, karate or gym. Patients having
sedentary life were considered ‘‘inactive’’.
 Thorough clinical examination including height, weight,
BMI, waist circumference (WC), stage of puberty and blood
pressure measurement. The latter was done on 2 separate
occasions and after 10 min rests using a sphygmomanometer.
 Assessment of glycemic control by calculating the mean
fasting (FBG) and 2 h postprandial blood glucose (PPBG)
for one month preceding the study, and the mean glycosy-
lated hemoglobin (HbA1c) over one year prior to the study.
Biochemical analysis
 Laboratory assessment for lipid proﬁle was done, after a 12-
h overnight fast, including: serum total cholesterol (TC) by
cholesterol oxidase–peroxidase method, serum triglycerides
(TG) by glycerokinase-peroxidase method, high density
lipoprotein-cholesterol (HDL-C) by Stanbio HDL-C
Procedure No. 0599 and low density lipoprotein-cholesterol
(LDL-C) = TC-(HDL-C)-(TG/5).
Dyslipidemia was deﬁned by the American Diabetes
Association (ADA)7 as having low density lipoprotein-choles-
terol (LDL-C) P100 mg/dl, high density lipoprotein-choles-
terol (HDL-C) <40 mg/dl (males) and <50 mg/dl (females),
total cholesterol (TC) P200 mg/dl and triglycerides (TG)
P150 mg/dl; and dyslipidemia was considered present if one
or more of these lipid or lipoprotein levels are abnormal.8
Statistical analysis
Data were statistically described in terms of mean (standard
deviation (±SD), median and range, or frequencies (number
of cases) and percentages when appropriate. Comparison of
numerical variables between the study groups was done using
Mann Whitney U test for independent samples. For compar-
ing categorical data, Chi square (v2) test was performed.
Exact test was used instead when the expected frequency is less
than 5. P values less than 0.05 were considered statistically sig-
niﬁcant. All statistical calculations were done using computer
programs SPSS (Statistical Package for the Social Science;
SPSS Inc., Chicago, IL, USA) version 15 for Microsoft
Windows.
Results
The sixty cases of children and adolescents with T1DM
included 34 males and the thirty-nine non-diabetic control sub-
jects included 18 males. The mean age was 12.5 (range 9.0–
19.5) years in cases and 12.0 ± 2.2 (range 9.0–16.0) years in
controls, p> 0.05.
The mean age at onset of diabetes in the studied group was
8.2 ± 2.6 (range 2.5–14.5) years, and the mean duration of
diabetes was 4.3 ± 2.7 (range 1.0–12.0) years and the mean
insulin dose was 1.1 ± 0.4 (range 0.5–2.7) IU/kg/day.
The frequency of dyslipidemia in the diabetic group was
65% (39/60) compared to 28.2% (11/39) in the control group
with highly signiﬁcant difference (p< 0.001).
Within the diabetic group, comparison of the fasting serum
lipid proﬁle (mean ± SD, and median) between those with
Table 1 Fasting serum lipid proﬁle of dyslipidemic and normolipidemic patients with diabetes.
Serum lipids Dyslipidemic group (n= 39) Normolipidemic group (n= 21) P-value
Mean ± SD Median Mean ± SD Median
TC (mg/dl) 175.3 ± 38.7 173.0 148.2 ± 32.9 153.0 0.007*
TG (mg/dl) 92.1 ± 43.7 84.0 64.3 ± 36.4 49.0 0.002*
HDL-C (mg/dl) 47 ± 18.6 44.1 53.1 ± 12.6 52.0 0.023*
LDL-C (mg/dl) 112.5 ± 34.2 113.0 82.4 ± 25.7 79.6 0.001*
TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol.
* Signiﬁcant <0.05.
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Figure 1 Percentage of different forms of dyslipidemia in type 1
diabetics showing that the most frequent form is high LDL-C with
low HDL-C.
Dyslipidemia in type 1 diabetes mellitus 65dyslipidemia and those with normolipidemia revealed signiﬁ-
cantly higher values of TC, TG and LDL-C, and signiﬁcantly
lower values of HDL-C in the former (Table 1).
The most frequent form of dyslipidemia found in the dys-
lipidemic group was high LDL-C with low HDL-C in
28.20%, followed by isolated high LDL-C in 20.51%.
Abnormality in all parameters of lipid proﬁle was found in
5.12% (Fig. 1).
Within the dyslipidemic group, more than 75% had high
LDL, either isolated or in association with other lipid abnor-
malities; and more than 55% had abnormally low HDL either
isolated or in association with other lipid abnormalities; while
the classic diabetic dyslipidemia in the form of hypertriglyc-
eridemia was much less frequent (2.6%).
Comparison between the dyslipidemic and normolipidemic
groups with T1DM regarding their demographic, clinical and
laboratory data revealed signiﬁcantly higher percentage of
female sex (p= 0.025), but comparable mean values of
chronological age, age at onset and duration of diabetes, and
insulin dose (Table 2).Table 2 Mean chronological age, age at onset and duration of diabe
Dyslipidemic group (n= 39)
Mean ± SD Median
Age (year) 12.8 ± 2.6 12.4
Age at onset of DM (year) 8.6 ± 2.8 8.7
Duration of DM (year) 4.1 ± 2.7 3.0
Insulin dosage (IU/kg/day) 1 ± 0.3 1.0
DM, diabetes mellitus.There was no signiﬁcant difference between the two groups
regarding the frequency of family history of diabetes and car-
diovascular risk.
The mean values of BMI, BMI SDS and WC were com-
pared and showed statistically signiﬁcant differences between
dyslipidemic and normolipidemic groups as regards BMI and
WC, p= 0.024 and 0.018, respectively (Table 3).
According to the mean BMI SDS, 6 patients (15.4%) were
obese (>+2 SD) in the dyslipidemic group [mean BMI
SDS = 0.9 ± 1.2], while in the normolipidemic group, one
patient (4.8%) was obese [mean BMI SDS = 0.4 ± 1.3] with
no signiﬁcant difference (p= 0.270).
Glycemic control of the two groups was compared regard-
ing the mean HbA1c over one year prior to the study, the mean
fasting and postprandial blood glucose. (FBG) and (PPBG),
over one month prior to the study, with no statistically signiﬁ-
cant difference (Table 4).
Comparison of degree of activity in both groups revealed
signiﬁcant difference, p= 0.033 (Table 5).
Comparison of dietary analysis of the two groups showed
no statistically signiﬁcant difference between the dyslipidemic
and normolipidemic diabetics (Table 6).
Discussion
In the present study, dyslipidemia was found in a signiﬁcantly
higher percentage of children and adolescents with type 1 dia-
betes (65%) compared to that of the non-diabetic control
group (28.2%). This agrees with Rahma et al. (2006) who
found that 66% of the children with T1DM were dyslipidemic
compared to 34% of the non-diabetic control group.9 Also this
agrees with the ﬁndings of Wiltshire et al. and Patiakas
et al.10,11
In the current study, the most frequent type of dyslipidemia
was high LDL-C and low HDL-C in 28.2% of the children
and adolescents with T1DM and dyslipidemia, while
high LDL-C and hypercholesterolemia with and withouttes, and insulin dose in dyslipidemic and normolipidemic groups.
Normolipidemic group (n= 21) P-value
Mean ± SD Median
12.1 ± 2 12.0 0.471
7.5 ± 2 7.3 0.104
4.6 ± 2.6 4.0 0.291
1.2 ± 0.5 1.1 0.512
Table 3 Mean values of anthropometric measures of dyslipidemic and normolipidemic groups.
Anthropometry Dyslipidemic group (n= 39) Normolipidemic group (n= 21) P-value
Mean ± SD Median Mean ± SD Median
BMI (kg/m2) 21.5 ± 5 21.1 19 ± 4.5 18.0 0.024*
BMI SDS 0.9 ± 1.2 0.8 0.4 ± 1.3 0.6 0.136
WC (cm) 80.3 ± 12 80.0 73.5 ± 12.7 70.0 0.018*
BMI SDS, body mass index standard deviation score; WC, waist circumference.
* Signiﬁcant <0.05.
Table 4 Mean HbA1c, FBG and PPBG in dyslipidemic and normolipidemic groups.
Glycemic control Dyslipidemic group (n= 39) Normolipidemic group (n= 21) P-value
Frequency Percent (%) Frequency Percent (%)
Mean HbA1c (%)
Good (<7.5) 15 38.5 11 52.4 0.412
Fair (7.5–9.0) 18 46.2 6 28.6
Poor (>9.0) 6 15.4 4 19.0
Mean FBG* (mg/dl)
Good (90–145) 4 10.3 3 14.3 0.452
Fair (>145) 6 15.4 1 4.8
Poor (>162) 29 74.4 17 81.0
Mean 2 h PPBG* (mg/dl)
Good (90–180) 15 38.5 8 38.1 0.672
Fair (180–250) 13 33.3 9 42.9
Poor (>250) 11 28.2 4 19.0
HbA1c, glycosylated hemoglobin; BG, blood glucose; FBG, fasting blood glucose; PPBG, postprandial blood glucose.
* BG (FBG and PPBG) is the mean of glucometer readings.
Table 5 Comparison of frequency of physical activity in dyslipidemic and normolipidemic groups.
Activity Dyslipidemic group (n= 39) Normolipidemic group (n= 21) P-value
Frequency Percent (%) Frequency Percent (%)
Inactive (sedentary life) 9 23.1 0 0.0 0.033*
Mild (regular activities) 24 61.5 19 90.5
Intense (regular sports) 6 15.4 2 9.5
* Signiﬁcant <0.05.
66 H.M. Mona et al.hypertriglyceridemia were found to be the most common types
in Al-Naama et al. and Rahma et al.9,12 The diabetic children
in these two studies showed high risk glycemic control
according to the mean fasting blood glucose (FBG)
(232.0 ± 92.0 mg/dl) and HbA1c (9.8 ± 4.2%).
Herman et al. (1998) and Kantoosh et al. (2002) reported
that in Egyptian diabetic children, hypertriglyceridemia was
the predominant type and reported signiﬁcantly higher serum
TG and HbA1c levels in the untreated freshly diagnosed chil-
dren with T1DM than that in the treated diabetics with good
glycemic control1.13,14 Patiakas et al. (2007) found that
hypercholesterolemia was the most frequent type and hyper-
triglyceridemia is the least frequent type in diabetic patients11
in contrast to Alrabaty et al. (2009) who stated that hyper-
triglyceridemia is the most common pattern of dyslipidemia
in children and adolescents with T1DM.15 These differences
are probably related to different glycemic controls across the
studies.
In this study, the female sex was signiﬁcantly higher in the
dyslipidemic group than the normolipidemic group (53.8% vs.23.8%, p= 0.025), this ﬁnding is in agreement with Krantz
et al. and Schwab et al.16,17 This ﬁnding is in contrast to the
results reported by Alrabaty et al. (2009) and Patiakas et al.
(2007) who found that there was no relationship between the
lipid abnormalities in children and adolescents with T1DM
and the gender.11,15
In the present work, mean duration of diabetes showed no
signiﬁcant difference between the dyslipidemic group and the
normolipidemic group (4.1 ± 2.7 and 4.6 ± 2.6 years respec-
tively); there were patients with less than 2 years diabetes dura-
tion and having dyslipidemia. This ﬁnding is in agreement with
Kanagalakshmi and Sultana (2012) and Guy et al. (2009) who
found that the dyslipidemia in children and adolescents with
T1DM is present despite short duration of diabetes.18,19 This
is in contrast to the results reported by Moayeri and Oloomi
(2006) who found that lipid concentrations correlate positively
with the duration of diabetes.20
In the present study, mean waist circumference (WC)
was signiﬁcantly higher in the dyslipidemic group than in
the normolipidemic group (80.3 ± 12.0 cm compared to
Table 6 Comparison of dietary analysis in dyslipidemic and normolipidemic groups.
Diet Dyslipidemic group (n= 39) Normolipidemic group (n= 21) P-value
Mean ± SD Median Mean ± SD Median
Fat in diet (gm/day) 51.8 ± 19.5 47.6 45.3 ± 18.4 40.3 0.180
CHO in diet (gm/day) 296.7 ± 100.8 286.8 283.8 ± 81.9 289.7 0.762
Protein in diet (gm/day) 66.4 ± 19.9 66.0 58.2 ± 27.5 57.0 0.143
Total calories (kcal/day) 1875.4 ± 561.8 1750.7 1721.0 ± 468 1763.7 0.434
Calories from fat (kcal/day) 466.1 ± 175.5 428.0 407.9 ± 165.7 363.0 0.180
CHO, carbohydrates.
Dyslipidemia in type 1 diabetes mellitus 6773.5 ± 12.7 cm, p= 0.018). This result is in concordance with
Teles and Forne´s (2012) and Kanagalakshmi and Sultana
(2012) who found higher WC in the dyslipidemic group than
the normolipidemic group of pediatric and youth populations
with T1DM.18,21
In this study, the majority of the dyslipidemic group
(46.2%) had suboptimal glycemic control [mean
HbA1c = 7.9 ± 1.0%], while in the normolipidemic group,
most of them (52.4%) had optimal control [mean
HbA1c = 8.0 ± 1.6%] with no signiﬁcant difference between
both groups regarding mean HbA1c. This result is in concor-
dance with Muchacka-Bianga et al. (2006) and Kantoosh
et al. (2002) who found that lipid disorders in children with
T1DM may be present regardless of their metabolic con-
trol.14,22 On the contrary, Teles and Forne´s (2012) and Guy
et al. (2009) found that poorer (inadequate) glycemic control
is related to higher serum lipids levels..19,21 Ladeia et al.
(2006) and Krantz et al. (2004) found signiﬁcant correlations
between glycemic control and lipids.16,23
In the current study, there was a signiﬁcant difference
between the dyslipidemic group and the normolipidemic group
as regards the degree of activity, p= 0.033. This agrees with
Schwab et al. (2006) and Muchacka-Bianga et al. (2006) who
stated that physical inactivity and dyslipidemia are potentially
atherogenic risk factors in children and adolescents with
T1DM.17,22
In the present work, mean daily caloric intake from dietary
fats was higher in the dyslipidemic group than in the
normolipidemic group but difference did not reach statistical
signiﬁcance (466.1 ± 175.5 kcal/day compared to 407.9 ±
165.7 kcal/day, p = 0.180). Similarly, Wiltshire et al. (2003)
who found that dietary fats do not contribute to hyperlipi-
demia in children and adolescents with T1DM and that hyper-
lipidemia relates primarily to metabolic control, with limited
impact from dietary factors. They suggested that treatment
of hyperlipidemia should primarily be directed at improving
metabolic control.10
Conclusion
Dyslipidemia in children and adolescents with type 1 diabetes
mellitus (T1DM) was signiﬁcantly more frequent than in non-
diabetic peers. Dyslipidemia was signiﬁcantly more frequent
among females with higher mean waist circumference (WC)
and physically inactive. The most frequent type of dyslipi-
demia was high LDL-C and low HDL-C in 28.2%.Conﬂict of interest
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Acknowledgements
We thank all children and their parents who participated in
this work. We would like to express our appreciation to our
colleagues and nurses at The Diabetes Endocrine and
Metabolism Pediatric Unit (DEMPU) who facilitated this
work.
References
1. Haller MJ, Samyn M, Nichols WW, Brusko T, Wasserfall C,
Schwartz F, Atkinson M, Shuster JJ, Pierce GL, Silverstein JH.
Radial artery tonometry demonstrates arterial stiffness in children
with type 1 diabetes. Diabetes Care 2004;27:2911–7.
2. Ho¨rtenhuber T, Rami-Mehar B, Satler M, Nagl K, Ho¨baus C,
Ho¨llerl F, Koppensteiner R, Schernthaner G, Schober E,
Schernthaner GH. Endothelial progenitor cells are related to
glycemic control in children with type 1 diabetes over time.
Diabetes Care 2013;36:1647–53.
3. Orchard TJ, Forrest KY, Kuller LH, Becker DJ. Pittsburgh
epidemiology of diabetes complications study. Lipid and blood
pressure treatment goals for type 1 diabetes: 10-year incidence
data from the Pittsburgh Epidemiology of Diabetes Complications
Study. Diabetes Care 2001;24:1053–9.
4. Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW,
Newburger JW, Parekh RS, Steinberger J. Cardiovascular risk
reduction in high-risk pediatric patients: a scientiﬁc statement
from the American Heart Association Expert Panel on Population
and Prevention Science; the Councils on Cardiovascular Disease in
the Young, Epidemiology and Prevention, Nutrition, Physical
Activity and Metabolism, High Blood Pressure Research,
Cardiovascular Nursing, and the Kidney in Heart Disease; and
the Interdisciplinary Working Group on Quality of Care and
Outcomes Research: endorsed by the American Academy of
Pediatrics. Circulation 2006;114:2710–38.
5. McCrindle BW, Urbina EM, Dennison BA, Jacobson MS,
Steinberger J, Rocchini AP, Hayman LL, Daniels S. Drug therapy
of high-risk lipid abnormalities in children and adolescents: a
scientiﬁc statement from the American Heart Association
Atherosclerosis, Hypertension, and Obesity in Youth
Committee, Council of Cardiovascular Disease in the Young,
with the Council on Cardiovascular Nursing. Circulation
2007;115:1948–67.
6. Donaghue KC, Wadwa RP, Dimeglio LA, Wong TY, Chiarelli F,
Marcovecchio ML, Salem M, Raza J, Hofman PL, Craig ME.
68 H.M. Mona et al.Microvascular and macrovascular complications in children and
adolescents. Pediatr Diabetes 2014;15(Suppl. 20):257–69.
7. Wysham C, Austin R, Braithwaite S, Funnell M, Gabbay R,
Grant R, Kadohiro J, Lenhard J, Lorber D, Magee M, Mudaliar
P, O’Connor P, Rao RH, Rhinehart A, Weinzimer S, Youssef G,
Fradkin J, Dunbar S, Kirkman S. Standards of medical care in
diabetes-2012. Diabetes Care 2012;35:S11–63.
8. Kwiterovich PO. Recognition and management of dyslipidemia in
children and adolescents. J Clin Endocrinol Metab 2008;93:
4200–9.
9. Rahma S, Rashid JA, Farage AH. The signiﬁcance of lipid
abnormalities in children with insulin dependent diabetes mellitus.
Iraqi Postgrad Med J 2006;5:289–94.
10. Wiltshire EJ, Hirte C, Couper JJ. Dietary fats do not contribute to
hyperlipidemia in children and adolescents with type 1 diabetes.
Diabetes Care 2003;26:1356–61.
11. Patiakas S, Kiriakopoulos N, Gavala C, Aggos I, Akritopoulou
P, Akritopoulos P, Xiropoulou E. The lipid proﬁle of patients with
diabetes mellitus in Paionia country. Diabetol Stoffwechs
2007;2:A35.
12. Al-Naama LM, Kadhim M, Al-Aboud MS. Lipid proﬁle in
children with insulin dependent diabetes mellitus. JPMA
2002;52:29–36.
13. Herman WH, Aubert RE, Engelgau MM, Thompson TJ, Ali MA,
Sous ES, et al. Diabetes mellitus in Egypt: glycaemic control and
microvascular and neuropathic complications. Diabet Med
1998;15:1045–51.
14. Kantoosh MM, Naiem AM, El-Sayad M, Nashat M.
Dyslipidemia and lipid peroxidation in type 1 diabetic children
with good glycemic control: response to antioxidant therapy. Alex
J Pediatr 2002;16:357–64.15. Alrabaty AA, Alnakshabandi AA, Yahya NB. The lipid proﬁle in
children with type 1 diabetes mellitus in Erbil governorate. Iraqi
Postgrad Med J 2009;8:344–9.
16. Krantz JS, Mack WJ, Hodis HN, Liu C-R, Liu C-H, Kaufman
FR. Early onset of subclinical atherosclerosis in young persons
with type 1 diabetes. J Pediatr 2004;145:452–7.
17. Schwab KO, Doerfer J, Hecker W, Grulich-Henn J, Wiemann D,
Kordonouri O, Beyer P, Holl RW. Spectrum and prevalence of
atherogenic risk factors in 27,358 children, adolescents and young
adults with type 1 diabetes. Diabetes Care 2006;29:218–25.
18. Kanagalakshmi K, Sultana M. A preliminary study of lipid
proﬁles in pediatric population and youth population with type 1
diabetes. Int J Pharm Biol Sci 2012;3:828–32.
19. Guy J, Ogden L, Wadwa RP, Hamman RF, Mayer-Davis EJ,
Liese AD, D’Agostino R, Marcovina S, Dabelea D. Lipid and
lipoprotein proﬁles in youth with and without type 1 diabetes.
Diabetes Care 2009;32:416–20.
20. Moayeri H, Oloomi Z. Prevalence of dyslipidemia in children and
adolescents with diabetes mellitus type I. Iran J Pediatr
2006;16:171–6.
21. Teles SA, Forne´s NS. Relationship between anthropometric and
biochemical proﬁles in children and adolescents with type 1
diabetes. Rev Paul Pediatr 2012;30:65–71.
22. Muchacka-Bianga M, Deja G, Jarosz-Chobot P, Maecka-Tendera
M, Kalina M, Grychto M. Evaluation of selected risk factors of
atherosclerosis in children with type 1 diabetes mellitus and
hypercholesterolemia. Endokrynol Diabetol Chor Przemiany
Materii Wieku Rozw 2006;12:25–30.
23. Ladeia AM, Adan L, Couto-Silva AC, Hiltner Aˆ, Guimara˜es AC.
Lipid proﬁle correlates with glycemic control in young patients
with type 1 diabetes mellitus. Prev Cardiol 2006;9:82–8.
